Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma
Clinical trial NCT01534078 · COMPLETED
Trial details
- NCT number
- NCT01534078
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2015-01-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.